Evidence map›Paper›PMID 29535626›Full record

ReviewFrontiers in pharmacology2018

Trace Amine Associated Receptor 1 (TAAR1) Modulation of Food Reward.

Catherine F Moore, Valentina Sabino, Pietro Cottone

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Frontiers in neuroscience · 2023
    Article
  6. Frontiers in psychiatry · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Catherine F MooreLaboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University School of Medicine, Boston, MA, United States.
Valentina SabinoLaboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University School of Medicine, Boston, MA, United States.
Pietro CottoneLaboratory of Addictive Disorders, Departments of Pharmacology and Psychiatry, Boston University School of Medicine, Boston, MA, United States.
Boston University · US

Funding

Role of Neuropeptides in AnxietyR01MH093650 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SABINO, VALENTINA · 2012 to 2016
$2.0M
Role of the Endocannabinoid System in Compulsive EatingR01MH091945 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COTTONE, PIETRO · 2010 to 2014
$2.0M
Involvement of neuropeptide systems in excessive alcohol drinkingR01AA025038 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SABINO, VALENTINA · 2017 to 2021
$1.8M
Prefrontal cortex in excessive alcohol drinking: role of sigma receptorsR01AA024439 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SABINO, VALENTINA · 2016 to 2020
$1.8M
Neurobiology of compulsive eating.R01DA030425 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COTTONE, PIETRO · 2011 to 2015
$1.6M
CRF modulation of reward function in compulsive eatingF31DA044664 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MOORE, CATHERINE FRANCES · 2017 to 2018
$82k
NIAAA NIH HHS R01 AA024439NIAAA NIH HHS R01 AA025038NIDA NIH HHS F31 DA044664NIDA NIH HHS R01 DA030425NIMH NIH HHS R01 MH091945NIMH NIH HHS R01 MH093650
6 · The paper itself

Abstract

Eating disorders and some forms of obesity are characterized by addictive-like, compulsive eating behavior which contains numerous similarities with compulsive drug use. Food intake is in part mediated by reward and reinforcement processes that can become dysregulated in these disorders. Additionally, impairments in inhibitory control regulation of reward-related responding can cause or further exacerbate binge and compulsive eating. Dysfunctions in two neurotransmitter systems in the mesocorticolimbic pathway, dopamine and glutamate, are thought to contribute to maladaptive eating behaviors. The trace amine associated receptor 1 (TAAR1) system is a promising therapeutic target for compulsive eating behavior due to the role of TAAR1 in synaptic transmission and in the modulation of dopaminergic and glutamatergic signaling. In support of this notion, the TAAR1 agonist RO5256390 was found to decrease the reinforcing effects of palatable food-cues and to reduce binge-like and compulsive-like eating of palatable food. Additionally, prolonged, intermittent access to palatable food was shown to downregulate TAAR1 in the prefrontal cortex, suggesting a potential role for TAAR1 signaling in inhibitory control processes. Research into the role of TAAR1 in addiction, including TAAR1's ability to modulate psychostimulant reward and reinforcement, bolsters support for TAAR1 agonism as a pharmacological treatment for compulsive eating and other addictive behaviors. This review summarizes the evidence for TAAR1 agonism as a promising therapeutic for compulsive eating behavior as well as the hypothesized mechanism responsible for these effects.

Indexed as

addictionbinge eatingcompulsiveinhibitory controlprefrontal cortex

Identifiers

PMID29535626
PMCPMC5835105
OpenAlexW2793967543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.